Binimetinib Market Key Companies and Analysis Top Trends by 2034

added article Health

2024-05-22 12:05:59 -

Binimetinib Market Overview A small molecule inhibitor called binimetinib is used to treat cancer by blocking the activity of mitogen-activated protein kinase (MAPK) kinase (MEK). It is sold under the Mektovi brand. Binimetinib functions by preventing the MAPK signaling pathway's MEK1 and MEK2 proteins from acting. This pathway, which is frequently dysregulated in cancer cells, is...

0 Comments 0 Shares 168 Views 0 Reviews